AtriCure

Website
Connect with early-career talent
Claim Company

AtriCure

Their mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Highlights

Early career talent

Percentage of all staff*
Early Talent Icon

Headcount growth

Last 12 months*
Headcount Icon

Entry level hires

Last 12 months*
New Hires

Funding / Market cap.

Latest funding round

Funding to date Icon

*LinkedIn data updated

December 14, 2023

Team highlights

Video play button

Great for Graduates and Interns

This Hotlist employer has great opportunities for graduates and interns. Here’s your snapshot of programs, when to apply, perks and more.

Highlights
Programmes available
What you need to know

Career progression

Where could this company take you? Discover how other early career professionals are shaping their career here.

No items found.

From LinkedIn data updated

14/12/2023

Great for Graduates and Interns

This Hotlist employer has great opportunities for graduates and interns. Here’s your snapshot of programs, when to apply, perks and more.

Job Families

Interns and graduates

Currently at the company

When to apply

Programs available

Icon for interns
Internships (Summer only)
Icon for interns
Internships (Summer / Winter)
Icon for interns
Internships (Year Round)
Icon for graduate fixed term programs
Grad Program (Fixed)
Icon for graduate rotation programs
Grad Program (Rotation)

What you need to know

Video play button

Hatch's hot take

What makes this company great for early career professionals? Here's what we think…

AI insights

Employee feedback

AI summarised feedback about AtriCure, based on Glassdoor company reviews.

Glassdoor rating

Last 12 months

Pros
Cons

Company review summaries are generated by artificial intelligence based on third-party sources and do not reflect opinions or beliefs held by Hatch. Hatch is not responsible for the accuracy of content of these summaries. For full reviews, please refer to the original sources.

More to love about AtriCure
Recent roles at AtriCure on Hatch
Check again soon to see roles from this company.
Explore more roles →

More of Australia's best companies

View more companies →

AtriCure

Website
Connect with early-career talent
Claim Company
Follow
26
No items found.
⚡️ Hatch Hotlist Company
Claim Company Profile
Claim Company Profile
Claim AtriCure's Hatch Profile

Talent teams looking to connect with the next generation of talent hire and promote their employer brand on Hatch.

Claim your profile to add content and get access to Australia’s leading source of early career talent.

You'll need an email address at AtriCure to take over their profile

Thank you! We'll be in touch shortly
Oops! Something went wrong while submitting the form.

Their mission

Our mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Early Talent Icon

Early career talent

Percentage of all staff*

Headcount Icon

Headcount growth

Last 12 months*

New Hires

Entry level hires

Last 12 months*

Funding to date Icon

Funding / Market cap.

Latest funding round

*LinkedIn data updated

14/12/2023

Company highlights

Their mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

What they do

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

  • Early Talent Icon

    Early career talent

    Percentage of all staff*

  • Headcount growth

    Last 12 months*

  • New Hires

    Entry level hires

    Last 12 months*

  • Funding to date Icon

    Funding

    All time^

  • *Linked In data updated

    14/12/2023

    ^Currency:

Life at Hatch

Team insights

Video play button

Our Story

The Hatch story started when good friends Adam Jacobs (Ex THE ICONIC Founder) and Chaz Heitner (Ex Zip Co-founder) came together to build something they were deeply passionate about.

Both founders believe that traditional hiring processes are broken and limit people from finding work that’s a good fit for them. Since founding the company, Adam and Chaz have built a team that shares their mission and are both confident they will continue to build an impactful global company for many years to come.

Video play button

Great for Graduates or Interns

AtriCure has great opportunities for graduates. Get a snapshot of the graduate programs or internships that may be available, when to apply, perks and more.
Highlights
Programmes available
What you need to know

Career progression

Where could this company take you? Discover how other early career professionals are shaping their career here.

No items found.

From LinkedIn data updated

14/12/2023

Hatch's hot take

Behind the scenes

What makes this company great for early career professionals? Here's what we think…

Want to join the team? This is what you're in for…

Great for Graduates and Interns

This Hotlist employer has great opportunities for graduates and interns. Here’s your snapshot of programs, when to apply, perks and more.

Job Families

Interns and graduates

Currently at the company

When to apply

Programs available

Icon for interns
Internships (Summer only)
Icon for interns
Internships (Summer / Winter)
Icon for interns
Internships (Year Round)
Icon for graduate fixed term programs
Grad Program (Fixed)
Icon for graduate rotation programs
Grad Program (Rotation)

What you need to know

Video play button
More to love about AtriCure

Their mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Early Talent Icon

Early career talent

Percentage of all staff

Headcount Icon

Headcount growth

Last 12 months

New Hires

Entry level hires

Last 12 months

Funding to date Icon

Funding to date

Team insights

Video play button

Why join now?

Hatch's hot take

What makes this company great for early career professionals? Here's what we think…

Their mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Great for Graduates and Interns

This Hotlist employer has great opportunities for graduates and interns. Here’s your snapshot of programs, when to apply, perks and more.

Job Families

Interns and graduates

Currently at the company

When to apply

Programs available

Icon for interns
Internships (Summer only)
Icon for interns
Internships (Summer / Winter)
Icon for interns
Internships (Year Round)
Icon for graduate fixed term programs
Grad Program (Fixed)
Icon for graduate rotation programs
Grad Program (Rotation)

What you need to know

Video play button

Why join now?

Their mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Early Talent Icon

Early career talent

Percentage of all staff*

Headcount Icon

Headcount growth

Last 12 months*

New Hires

Entry level hires

Last 12 months*

501-1,000 employees

Employee Headcount

Estimated

Company stage

Last 12 months*

Glassdoor rating

Last 12 months*

Funding to date Icon

Funding / Market cap.

*LinkedIn data updated

14/12/2023

AI insights

AI summarised employee feedback about AtriCure, based on Glassdoor company reviews:

Glassdoor rating

Last 12 months

Pros
Cons

Company review summaries are generated by artificial intelligence based on third-party sources and do not reflect opinions or beliefs held by Hatch. Hatch is not responsible for the accuracy of content of these summaries. For full reviews, please refer to the original sources.

Team highlights

Video play button

Career progression

Where could this company take you? Discover how other early career professionals are shaping their career here.

No items found.

From LinkedIn data updated

14/12/2023

Hatch's hot take

What makes this company great for early career professionals? Here's what we think…

More to love about AtriCure

Their mission

We are passionately focused on reducing the global Afib epidemic and healing the lives of those affected.

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

Early Talent Icon

Early career talent

Percentage of all staff*

Headcount Icon

Headcount growth

Last 12 months*

New Hires

Entry level hires

Last 12 months*

501-1,000 employees

Employee Headcount

Estimated

Company stage

Last 12 months*

Glassdoor rating

Last 12 months*

Funding to date Icon

Funding / Market cap.

*LinkedIn data updated

14/12/2023

AI insights

AI summarised employee feedback about AtriCure, based on Glassdoor company reviews:

Glassdoor rating

Last 12 months

Pros
Cons

Company review summaries are generated by artificial intelligence based on third-party sources and do not reflect opinions or beliefs held by Hatch. Hatch is not responsible for the accuracy of content of these summaries. For full reviews, please refer to the original sources.

Team highlights

Video play button

Career progression

Where could this company take you? Discover how other early career professionals are shaping their career here.

No items found.

From LinkedIn data updated

14/12/2023

Hatch's hot take

What makes this company great for early career professionals? Here's what we think…

More to love about AtriCure

We're hiring!

Recent roles at AtriCure on Hatch
Check again soon to see roles from this company.

More of Australia's best companies